The Food and Drug Administration (FDA) has granted 510(k) clearance to Trax Surgical’s LINKT compression staple system for ...

Cortechs.ai has announced a strategic partnership with ALZ-NET aimed at improving the quality of care for Alzheimer's.

Tempus AI is expanding its partnership with Verastem Oncology to develop a companion diagnostic (CDx) for the latter’s KRAS-mutant recurrent LGSOC combination treatment.

PHASE Scientific International has completed a Series A funding round, raising $34m for progressing the PHASIFY diagnostic.

Biosense Webster was deemed to have violated antitrust laws by withholding clinical support to hospitals using Innovative’s ...

The sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.

Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the ...

Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke ...

British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an ‘aggressive’ ...

Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...